CervoMed Inc. Increase (Decrease) in Accounts Receivable
CervoMed Inc. (CRVO) reported Increase (Decrease) in Accounts Receivable of -$426.99 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-07
- CervoMed Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$426.99K.
- CervoMed Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$934.39K, a 146.95% decline year-over-year.
- CervoMed Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$999.59K, a 478.42% decline year-over-year.
- CervoMed Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$1.83M, a 236.48% decline from fiscal 2024.
- CervoMed Inc. increase (decrease) in accounts receivable for fiscal 2024 was $1.34M, a 46.26% increase from fiscal 2023.
- CervoMed Inc. increase (decrease) in accounts receivable for fiscal 2023 was $915.40K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$426.99K 10-Q · filed 2026-08-07 | -$1.36M derived: sum of 3 quarters · filed 2026-08-07 | -$2.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$426.99K 10-Q · filed 2026-05-15 | -$1.36M derived: sum of 2 quarters · filed 2026-05-15 | -$2.36M derived: sum of 3 quarters · filed 2026-05-15 | -$1.63M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$934.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.93M derived: sum of 2 quarters · filed 2026-03-13 | -$1.20M derived: sum of 3 quarters · filed 2026-08-07 | -$1.83M 10-K · filed 2026-03-13 |
| 2025-09-30 | -$999.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$267.84K derived: sum of 2 quarters · filed 2026-08-07 | -$892.84K 10-Q · filed 2025-11-07 | $1.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $731.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $106.74K 10-Q · filed 2026-08-07 | $2.10M derived: sum of 3 quarters · filed 2026-08-07 | $2.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$625.00K 10-Q · filed 2026-05-15 | $1.37M derived: sum of 2 quarters · filed 2026-05-15 | $1.63M derived: sum of 3 quarters · filed 2026-05-15 | $1.63M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $2.25M derived: sum of 2 quarters · filed 2026-03-13 | $2.25M derived: sum of 3 quarters · filed 2026-03-13 | $1.34M 10-K · filed 2026-03-13 |
| 2024-09-30 | $264.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $264.15K derived: sum of 2 quarters · filed 2025-11-07 | -$651.26K 10-Q · filed 2025-11-07 | $264.15K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$915.40K 10-Q · filed 2025-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-08-08 | $0.00 derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$915.40K 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-12 | |
| 2023-12-31 | $915.40K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $915.40K derived: sum of 2 quarters · filed 2025-03-17 | $915.40K 10-K · filed 2025-03-17 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2012-06-30 | $71.67K 10-Q/A · filed 2012-09-07 | |||
| 2011-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | -$58.50K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | -$53.50K 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |